Overexpression of S100A9 in obesity impairs macrophage differentiation via TLR4-NFkB-signaling worsening inflammation and wound healing
Correlation between levels of S100A9 or galectin‐3 and fasting blood... | Download Scientific Diagram
A step closer to a life without insulin thanks to a Swiss research - IO
Major diabetes discovery brings life without insulin closer to reality
S100A9 antibody (14226-1-AP) | Proteintech
Groundbreaking diabetes discovery brings the world closer to life without insulin
Forschungspreis - Schweizerische Diabetes-Stiftung
Correlation between systemic S100A8 and S100A9 levels and severity of diabetic retinopathy in patients with type 2 diabetes mellitus - ScienceDirect
S100A9-RAGE Axis Accelerates Formation of Macrophage-Mediated Extracellular Vesicle Microcalcification in Diabetes Mellitus | Arteriosclerosis, Thrombosis, and Vascular Biology
Diabetes: Ein weiterer Schritt zu einem Leben ohne Insulin | myScience / news / news 2022
Overexpression of S100A9 in obesity impairs macrophage differentiation via TLR4-NFkB-signaling worsening inflammation and wound healing
IJMS | Free Full-Text | Pro-Inflammatory S100A8 and S100A9 Proteins: Self-Assembly into Multifunctional Native and Amyloid Complexes
S100A8 and S100A9 in Cardiovascular Biology and Disease | Arteriosclerosis, Thrombosis, and Vascular Biology
Diabetes breakthrough brings world closer to life without insulin | The Independent
S100A9 in adult asthmatic patients: a biomarker for neutrophilic asthma | Experimental & Molecular Medicine
Evaluating serum levels of S100A9 as an inflammatory marker of unfavorable outcomes in patients with COVID-19
S100A8 and S100A9 in cardiovascular biology and disease. | Semantic Scholar
Proposed function(s) of S100A8/S100A9 in WAT. In normal physiological... | Download Scientific Diagram
Remarkable protein could revolutionize type 2 diabetes treatment
THE PROBLEM: treatment of type 1 diabetes is suboptimal OUR SOLUTION: S100A9 –protein based treatment to make insulin therap
THE PROBLEM: treatment of type 1 diabetes is suboptimal OUR SOLUTION: S100A9 –protein based treatment to make insulin therap
Biospecimen CRO services for Diabetes therapy research • BIOMEDICA CRO
JCI - Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes
Frontiers | Epigenetic Regulation of S100A9 and S100A12 Expression in Monocyte-Macrophage System in Hyperglycemic Conditions
Frontiers | S100A8/A9 in Myocardial Infarction: A Promising Biomarker and Therapeutic Target
Hepatic non-parenchymal S100A9-TLR4-mTORC1 axis normalizes diabetic ketogenesis | Nature Communications
